dbo:abstract
|
- Dharmacon Inc., now known as Dharmacon, was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis. Originally, the company's focus was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and technologies. When RNA interference (RNAi) emerged in the late 1990s, Dharmacon was poised to provide RNAi-related products to the multitude of academic and industry researchers. Dharmacon has become an important resource for those investigating the mechanisms of siRNA (small interfering RNA)-induced gene knockdown and applying the specificity and potency of RNAi to human biotherapeutics. Dharmacon's expertise in bioinformatics, RNA biology, and synthesis chemistry has allowed it to develop a complete line of products for the RNAi researcher. (en)
|
dbo:foundingYear
| |
dbo:industry
| |
dbo:location
| |
dbo:numberOfEmployees
|
- 150 (xsd:nonNegativeInteger)
|
dbo:product
| |
dbo:type
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 6547 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:foundation
| |
dbp:industry
| |
dbp:location
| |
dbp:name
| |
dbp:numEmployees
| |
dbp:products
|
- CRISPR, RNAi, siRNA, miRNA, shRNA, cDNA, ORFs, Transfection Reagents (en)
|
dbp:type
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- Dharmacon Inc., now known as Dharmacon, was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis. Originally, the company's focus was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and technologies. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:isPrimaryTopicOf
| |
foaf:name
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |